Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, Nagasaki, Nagasaki 852‑8588, Japan.
Department of Molecular and Developmental Biology, Kawasaki Medical School, Kurashiki, Okayama 701‑0192, Japan.
Int J Oncol. 2019 Mar;54(3):1021-1032. doi: 10.3892/ijo.2018.4667. Epub 2018 Dec 14.
Dickkopf‑related protein 3 (DKK3), which is a member of the Dickkopf WNT signaling pathway inhibitor family, is considered to be a tumor suppressor, due to its reduced expression in cancer cells and its ability to induce apoptosis when overexpressed by adenovirus. However, our previous study demonstrated alternative functions for DKK3 in head and neck squamous cell carcinoma (HNSCC). Our study reported that DKK3 expression was predominantly upregulated in HNSCC cell lines and tissue samples, and its expression was significantly correlated with poor prognosis. Furthermore, DKK3 overexpression in HNSCC cells significantly increased cancer cell proliferation, migration, invasion and in vivo tumor growth. These data have led to the hypothesis that DKK3 may exert oncogenic functions and may increase the malignant properties of HNSCC. The present study established a stable DKK3 knockdown cell line (HSC‑3 shDKK3) using lentivirus‑mediated short hairpin RNA, and assessed its effects on cancer cell behavior using MTT, migration and invasion assays. In addition, its effects on in vivo tumor growth were assessed using a xenograft model. Furthermore, the molecular mechanisms underlying the effects of DKK3 knockdown were investigated by microarray analysis, pathway analysis and western blotting. Compared with control cells, HSC‑3 shDKK3 cells exhibited significantly reduced proliferation, migration and invasion, and formed significantly smaller tumor masses when subcutaneously transplanted into nude mice. In addition, in HSC‑3 shDKK3 cells, the expression levels of phosphorylated (p)‑protein kinase B (Akt) (Ser473), p‑phosphoinositide 3‑kinase (PI3K) p85 (Tyr467), p‑PI3K p55 (Try199), p‑3‑phosphoinositide‑dependent protein kinase‑1 (PDK1) (Ser241) and total p38 mitogen‑activated protein kinase (MAPK) were reduced. Furthermore, phosphorylation of mechanistic target of rapamycin (mTOR) (Ser2448) was slightly decreased in HSC‑3 shDKK3 cells, which may be due to the increased expression of DEP domain‑containing mTOR‑interacting protein. Conversely, DKK3 overexpression in HSC‑3 shDKK3 cells rescued cellular proliferation, migration and invasion. With regards to expression levels, p‑PI3K and p‑PDK1 expression was not altered, whereas mTOR and p‑p38 MAPK expression was elevated. These data supported the hypothesis and indicated that DKK3 may contribute to the malignant phenotype of HNSCC cells via the PI3K/Akt/mTOR and MAPK signaling pathways.
Dickkopf 相关蛋白 3(DKK3)是 Dickkopf WNT 信号通路抑制剂家族的成员,被认为是一种肿瘤抑制因子,因为其在癌细胞中的表达减少,并且当其通过腺病毒过表达时能够诱导细胞凋亡。然而,我们之前的研究表明 DKK3 在头颈部鳞状细胞癌(HNSCC)中有不同的功能。我们的研究报告称,DKK3 在 HNSCC 细胞系和组织样本中的表达明显上调,其表达与预后不良显著相关。此外,DKK3 在 HNSCC 细胞中的过表达显著增加了癌细胞的增殖、迁移、侵袭和体内肿瘤生长。这些数据导致了这样的假设,即 DKK3 可能发挥致癌功能,并可能增加 HNSCC 的恶性特性。本研究使用慢病毒介导的短发夹 RNA 建立了稳定的 DKK3 敲低细胞系(HSC-3 shDKK3),并通过 MTT、迁移和侵袭测定评估了其对癌细胞行为的影响。此外,还通过异种移植模型评估了其对体内肿瘤生长的影响。此外,通过微阵列分析、通路分析和 Western blot 研究了 DKK3 敲低作用的分子机制。与对照细胞相比,HSC-3 shDKK3 细胞的增殖、迁移和侵袭明显减少,并且在皮下移植到裸鼠中时形成的肿瘤体积明显较小。此外,在 HSC-3 shDKK3 细胞中,磷酸化(p)蛋白激酶 B(Akt)(Ser473)、磷酸肌醇 3-激酶(PI3K)p85(Tyr467)、p-PI3K p55(Try199)、p-3-磷酸肌醇依赖性蛋白激酶-1(PDK1)(Ser241)和总 p38 丝裂原活化蛋白激酶(MAPK)的表达水平降低。此外,HSC-3 shDKK3 细胞中雷帕霉素(mTOR)的磷酸化(Ser2448)略有降低,这可能是由于 DEP 结构域包含的 mTOR 相互作用蛋白的表达增加所致。相反,在 HSC-3 shDKK3 细胞中转染 DKK3 过表达可挽救细胞增殖、迁移和侵袭。关于表达水平,p-PI3K 和 p-PDK1 的表达没有改变,而 mTOR 和 p-p38 MAPK 的表达升高。这些数据支持了假设,并表明 DKK3 可能通过 PI3K/Akt/mTOR 和 MAPK 信号通路促进 HNSCC 细胞的恶性表型。